General Catalyst Group Management, LLC
CAMBRIDGE, MA · Quarter end: Sep 30, 2026 · Filed with SEC: Nov 16, 2026 · Open the SEC source ↗
Portfolio Return (1Y)——
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.$478.2M2026 Q3
Positions13
Top-10 ConcentrationPercent of the portfolio in the 10 largest holdings. High means the fund is concentrated in few stocks.99.8%
What Changed This Quarter?
Top Holdings
QCOM
Qualcomm
60.9%
PBLS
Parabilis Medicines
10.8%
AVBP
ArriVent BioPharma
9.5%
CART
Maplebear
6.4%
MAZE
Maze Therapeutics
5.9%
ODTX
Odyssey Therapeutics
3.8%
OSCR
Oscar Health
1.9%
CPNG
Coupang
0.2%
New / Increased
3 new · 2 increased
QCOMNEW
Qualcomm
60.9%
OSCRNEW
Oscar Health
1.9%
MLMNEW
Martin Marietta Matls
0.0%
CPNG
Coupang
0.2%
+44.8%
CVNA
Carvana
0.1%
+35.6%
Reduced / Exited
2 reduced · 4 sold out
DASH
DoorDash
0.0%
-54.4%
AMZN
Amazon
0.2%
-9.0%
EIKNEXIT
Eikon Therapeutics
2.1%
Fractyl Healt…EXIT
Fractyl Health
2.1%
LIFEEXIT
Ethos Technologies
0.7%
FIGEXIT
Figma
0.1%
Read the 2026-Q2 quarterly report · 13F Filing Calendar
13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.